Welcome to PsychU!

Impact of Adherence on Patients with BP I Disorder

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Impact of Adherence on Patients with BP I Disorder

Treatment non-adherence is a dilemma in bipolar disorder and is one of the leading challenges in providing effective treatments for people diagnosed with BP I disorder. During our discussion today, Dr. Sajatovic and Dr. Goldberg will discuss and define some of these challenges and provide the latest information on treatment-related determinants of adherence. They will also discuss some of the factors important to adherence.

FEATURING

Martha-Sajatovic

Martha Sajatovic, MD

Psychiatrist, Director Neurological and Behavioral Outcomes Center, University Hospital Cleveland Medical Center and Professor, Case Western Reserve University School of Medicine

Joseph-Goldberg

Joseph Goldberg, MD

Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai, Director of the Affective Disorder Research Program at Silver Hill Hospital

More
Dr. Goldberg currently serves as the Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and serves on the Board of Directors for the American Society of Clinical Psychopharmacology. Dr. Goldberg has published over 200 peer-reviewed papers on topics related to the treatment and clinical features of bipolar disorder, as well as three books on bipolar disorder and psychopharmacology.
Elizabeth-DiNapoli

Elizabeth DiNapoli, PhD (OPDC)

Senior Clinical & Scientific Liaison

More
Dr. DiNapoli earned her PhD from the University of Alabama.

Speakers Martha Sajatovic, MD and Joseph Goldberg, MD are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc.
Speakers Elizabeth DiNapoli, PhD, is a paid employee of Otsuka Pharmaceutical Development & Commercialization, Inc.

Registration

Registration is closed for this event.

Related Resources